SC-535, a Novel Oral Multikinase Inhibitor, Showed Potent Antitumor Activity in Human Melanoma Models
Background: Melanoma is considered as one of the most aggressive and deadliest cancers and current targeted therapies of melanoma often suffer limited efficacy or drug resistance. Discovery of novel multikinase inhibitors as anti-melanoma drug candidates is still needed. Methods: In this investigati...
Main Authors: | Xin Chen, Pan Ji, Hui-Wen Yang, Ling-Ling Yang, Shu Zhou, Lei Zhong, Shuang Ma, Xiao-Yu Fu, Chan Zhou, Guo-Bo Li, Ming-Wu Zheng, Yu-Quan Wei, Sheng-Yong Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2013-07-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/350123 |
Similar Items
-
Computer-aided design and synthesis of 3-carbonyl-5-phenyl-1H-pyrazole as highly selective and potent BRAFV600E and CRAF inhibitor
by: Jinwoong Kim, et al.
Published: (2019-01-01) -
Depictions of ships on roman lamps
by: Karolina Trusz
Published: (2015-12-01) -
Angiogenesis and Melanoma
by: Vito Longo, et al.
Published: (2010-02-01) -
Combining Bevacizumab with Endostatin Gets Better Antitumor Efficacy in Vivo
in Lung Cancer Animal Model
by: Niu NIU, et al.
Published: (2013-02-01) -
¿Por qué se está usando otra vez la talidomida? Why is thalidomide back?
by: Emilio Sanín Pérez, et al.
Published: (2004-02-01)